Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

AUGUST 10, 2021

A new article published in Drugs: Education, Prevention and Policy discusses the importance, and challenges, of racial equity within the resurgent field of psychedelic-assisted mental health treatment.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Mitchell et al., Divito & Robert F. Psychiatry May Never Be the Same , N.Y. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. RYAH Smart inhalers are being used in a huge clinical trial based in the UK. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

DECEMBER 2, 2021

Equity subcommittee members raised concerns regarding the background check requirement, expressing worry such a requirement will disparately impact individuals from communities disproportionately targeted by law enforcement. An amendment to drop the background check requirement was proposed but failed to pass.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

SEPTEMBER 22, 2021

This change would mean it would be easier to run trials on its use in mental health treatments. The Prime Minister had already approved the rescheduling of psilocybin for exploring its potential as a treatment for depression, which he informed Mr Blunt in a meeting in May.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

PrestoDoctor

OCTOBER 11, 2023

However, as part of a comprehensive treatment plan, CBD may offer a complementary approach to address some of the social symptoms associated with ASD. Another study involving human participants reported a significant reduction in anxiety and improvement in social communication skills after CBD treatment.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Cannabis Law Report

MAY 19, 2022

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

DECEMBER 9, 2021

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. Except as required by law, the Company does not intend and does not assume any obligation to update this forward-looking information.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

JUNE 19, 2022

In the United States, there are two leading drug-assisted therapies in phase 3 clinical trials testing MDMA (ecstasy) as a treatment for post-traumatic stress disorder and psilocybin for depression. Our capacity to reach so many makes this commitment essential.”.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2019

Severe treatment-resistant epilepsy. Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is a limited liability corporation formed under the laws of Arizona , which operates 10 ketamine infusion treatment clinics, across Arizona , Colorado , Florida , Illinois , Minnesota , Nevada , Texas , and Washington. Transaction Highlights. business for 6 years expanding services throughout the United States.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

DECEMBER 11, 2021

Department records show that the health condition of 74% of patients improves after such treatment. “Our plan is to open more cannabis clinics to cover most of the tambons across the nation,” Dr Kwanchai said. Can you elaborate on the cannabis oil treatment available at these clinics?

Oil 52

Oil Blood Pressure Concentrates Patients 52

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. They also wrote: The study sample included participants with a history of cannabis use.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

DECEMBER 28, 2021

Marijuana has a long history, including good and bad days. This is because Epidiolex has been proven an effective treatment after going through various clinical trials. Once taking the name of marijuana was considered a sin, and its consumption was a crime. So, there are huge developments after that.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

MARCH 2, 2020

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

JANUARY 24, 2022

In addition, as countries in the region are actively liberalizing laws related to marijuana, the market is likely to witness increased demand for cannabis-based products as well as their derivatives. Growing adoption of medical marijuana for treatment of chronic diseases. History of Medical Use of Cannabis in North America.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

NOVEMBER 24, 2019

Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. December 3, 2019. December 4, 2019.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Cannabis Law Report

DECEMBER 14, 2019

Now, unless the patient is under 16 years old or has a history of drug abuse, medical practitioners in New South Wales can prescribe cannabis medicines without having to refer to a specialist. In fact, the company is preparing the first human trials of a proprietary drug system that delivers synthetic CBD-based medicines to the skin.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

APRIL 10, 2019

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. The law was changed on 1 November last year to ensure that it is now legal for doctors on the specialist register of the General Medical Council to prescribe cannabis-based products for medicinal use in the UK.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

JUNE 11, 2019

This controversy is evident in the case law reviewed. He had a history of drug use both before and after the accidents that included cocaine, heroin, and crystal meth. At the time of trial, McCallum was on methadone and medical marijuana. Gordon had a significant history of drug use.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

DECEMBER 21, 2021

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. In its history, IHG has graduated nearly 8,000 students.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

DECEMBER 7, 2021

Derived from the iboga shrub native to West Africa, it has a history as a spiritual sacrament in the Bwiti religion in the country of Gabon. Ibogaine is not the ideal addiction-treatment drug; it can cause cardiac arrhythmia (an irregular heartbeat) and its intense psychedelic experience is not for everyone.

Treatment 52

Treatment Clinical Trials Data Conditions 52

Cannabis Law Report

AUGUST 22, 2021

The addition of methylated tryptamines with pending patent protection is focused on the potential improvement of treatments for mental health conditions including depression, anxiety and addiction, as well as other psychological and neurologic conditions. ” About PsyBio Therapeutics Corp.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

SpeedWeed

JULY 7, 2021

One single dose of mescaline may be a helpful treatment for people who are struggling with addiction, depression, anxiety, or PTSD , according to a new study published in the ACS Pharmacology & Translational Science journal. . Mescaline-containing San Pedro cactus (Image via ). View original article.

Clinical Trials 52

Clinical Trials Treatment Decriminalization Conditions 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 22, 2021

(NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S.

Clinical Trials 52

Clinical Trials Treatment Business Events 52

Cannabis Law Report

NOVEMBER 1, 2021

The Liver Meeting, which takes place virtually on November 12 – 15, 2021, brings together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.

Clinical Trials 52

Clinical Trials Research and Development Treatment Business 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 59

Research and Development CBD Conditions Therapy 59

Cannabis Law Report

NOVEMBER 24, 2021

The Cannabis sativa plant has an incredibly multi-layered, rich, and versatile history of human uses for food and fibre, as well as recreational, and religious and spiritual purposes throughout the world (McPartland and Hegman 2018 ; Aldrich 1997 ; Touw 1981 ; Li 1974 ; Bonini et al. 2018 ; Frankhauser 2008 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 19, 2019

This legal opinion considers the mischief behind the laws proscribing the production, possession, sale and use of Marijuana and thereafter considers the benefits of legalizing Marijuana in Nigeria. Deemed an illicit drug by the law, it had always been an offence in Nigeria to smoke marijuana, and it has largely been frowned upon by society.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45